Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo

Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform,…

Read More
BioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

BioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

The British drugmaker is paying up to $1…

Read More
Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

Validation Completed for a Novel, Cost-Competitive Epinephrine Active…

Read More
The Economic Power of NIH Grants: Why Sustained Investment Matters

The Economic Power of NIH Grants: Why Sustained Investment Matters

The National Institutes of Health (NIH) is vital…

Read More
Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support

Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support

HONOLULU, HI, Mar. 12, 2025 – Motivity, a…

Read More
WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO

WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO

By Sara Gilgore – Staff Reporter, Washington Business…

Read More
CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners

CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today…

Read More
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) --…

Read More
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in…

Read More
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions…

Read More
Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville, Md. (March 11, 2025) – Cellphire Therapeutics,…

Read More
IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a…

Read More
647th Edition, March 11, 2024

647th Edition, March 11, 2024

    MCCC Trends in Life Science Event:…

Read More
Syngene Acquires its First Manufacturing Facility in Baltimore

Syngene Acquires its First Manufacturing Facility in Baltimore

BANGALORE, India, March 10, 2025 /PRNewswire/ -- Syngene International Limited…

Read More
MCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker

MCCC Trends in Life Science Event: Exploring Industry Shifts, Regulations, and Growth Opportunities – Rich Bendis Keynote Speaker

The life sciences industry is constantly evolving, influenced…

Read More
Altimmune to Host Virtual R&D Day on March 13, 2025

Altimmune to Host Virtual R&D Day on March 13, 2025

GAITHERSBURG, M.D., March 06, 2025 (GLOBE NEWSWIRE) -- Altimmune,…

Read More
WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

WBJ: New York health-tech company Claritev moves headquarters to Northern Virginia

By Sara Gilgore – Staff Reporter, Washington Business…

Read More
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN;…

Read More
Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

Ascentage Pharma’s Olverembatinib Granted Breakthrough Therapy Designation for Ph+ Acute Lymphoblastic Leukemia (ALL)

ROCKVILLE, Md. and SUZHOU, China, March 05, 2025…

Read More
USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts to reduce risk and increase supply chain reliability for patients

USP publishes Vulnerable Medicines List to inform efforts…

Read More
TEDCO Invests in Irazú Oncology

TEDCO Invests in Irazú Oncology

Life sciences company developing a cost-effective production process…

Read More
REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

REGENXBIO Announces Closing of Strategic Partnership with Nippon Shinyaku for MPS Diseases

ROCKVILLE, Md., March 4, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX)…

Read More
IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

IGC Pharma Expands AI Platform With Advanced Diagnostic Model for Alzheimer’s and Dementia Detection

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC…

Read More
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in…

Read More